In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee:
Times and Dates
8 a.m.-6 p.m., October 24, 2012.
8 a.m.-4 p.m., October 25, 2012.
Place: Centers for Disease Control and Prevention, Tom Harkin Global Communications Center, 1600 Clifton Road NE., Building 19, Kent “Oz” Nelson Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Further, under provisions of the Affordable Care Act, at section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been adopted by the Director of the Centers for Disease Control and Prevention must be covered by applicable health plans.
Matters To Be Discussed: The agenda will include discussions on: 2013 adult immunization schedule, 2013 child/adolescent immunization schedule, Japanese encephalitis, rotavirus, human papillomavirus vaccines, hepatitis B vaccine, meningococcal vaccines, influenza, measles-mumps-rubella vaccine, pertussis and vaccine supply. Recommendation votes are scheduled for pertussis vaccines, meningococcal vaccines, measles-mumps-rubella vaccine, hepatitis B vaccine, child/adolescent immunization schedule, and the adult immunization schedule. VFC votes are scheduled for pertussis vaccines, meningococcal vaccines, and influenza vaccine. Time will be available for public comment.
Agenda items are subject to change as priorities dictate.
Meeting is webcast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP web site: http://www.cdc.gov/vaccines/acip/index.html.
Contact Person for More Information: Stephanie B. Thomas, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE., MS-A27, Atlanta, Georgia 30333, telephone 404/639-8836; Email ACIP@CDC.GOV.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: September 14, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2012-23390 Filed 9-21-12; 8:45 am]
BILLING CODE 4160-18-P